Navigation Links
Synedgen's Synoplex® is Headed to the Lewa Wildlife Conservancy in Kenya
Date:8/6/2013

Claremont, CA (PRWEB) August 06, 2013

Synedgen is donating a supply of its veterinary wound rinse product Synoplex®, designed to treat infected, chronic and non-infected wounds in elephants and rhinoceros, to the Lewa Wildlife Conservancy. The donation is in honor of the late Anna Merz, a world champion of black rhinoceroses and animal conservation, who helped start Lewa in response to the poaching and slaughter of rhinoceroses.

“Synedgen applauds the efforts of the Lewa Conservancy, and would like to contribute to the legacy of Anna Merz. We hope Lewa will find Synoplex to be helpful in their efforts to treat wounds and improve healing not only in rhinos, but other pachyderms in the Conservancy,” stated Synedgen president Shenda Baker.

“This donation marks the first use of Synoplex in the wild, and we are proud to support Lewa’s conservation effort,” added Synedgen CEO William Wiesmann. “We are particularly pleased that the active ingredients in Synoplex are biodegradable and will not harm the environment.”

Founded in 1995, the Lewa Wildlife Conservancy (http://www.lewa.org) spans 61,000 acres and serves as catalyst for conservation across northern Kenya. Lewa holds 11% of Kenya’s black rhino population and 20% of the world’s Grevy’s zebras. Through the protection and management of endangered species, the initiation and support of community conservation and development programs, and the education of neighboring communities in the value of wildlife, Lewa has become a model in Kenya for wildlife conservation on private land, a favored destination for low impact tourism, and a leading catalyst for development centric conservation in northern Kenya. The Conservancy is also home to the Northern Rangelands Trust, an innovative community conservation partnership where upwards of 25 communities, spanning over three million acres of land to the north of Lewa, have embraced wildlife conservation as part of their vision for development of the people and land on which they live.

Lewa Executive Director Ginger Thomson stated, “We are grateful to Synedgen for providing our hard-working team at Lewa, led by Matthew Matunda of the Kenya Wildlife Service, an opportunity to use Synoplex with our rhinoceroses. We currently have more than 130 rhino within the Conservancy's fences, and we work with several other conservancies on rhino conservation, leading efforts to bring the newest technologies and science to preserve this iconic animal in the wild. As an experienced wildlife vet, Matunda was thrilled to be one of the first to use Synoplex directly in the field.”

Synoplex is legally marketed as an FDA Indexed Product under MIF 900-012, and is available directly from Synedgen.

About Synedgen
Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary and gastrointestinal surfaces. Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at http://www.synedgen.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10999306.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
2. Prolongs Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran
3. Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So
4. Elsevier Launches International Journal for Parasitology: Parasites and Wildlife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... York, New York (PRWEB) , ... ... ... Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human ... and immunotherapies for infectious diseases and cancer. , The Human Vaccines ...
(Date:2/10/2016)... Feb. 10, 2016  Matchbook, Inc., a company ... growing biotech companies, announced today the appointment of ... Advisor. Jim brings nearly 25 years of experience ... having spent nearly two decades in executive level ... Procurement at Genzyme and, most recently headed global ...
(Date:2/10/2016)... , ... February 10, 2016 , ... LATHAM, NEW YORK... ... the SPIE Photonics West conference in San Francisco’s Moscone Center from February ... the same venue. , These latest InGaAs PIN diode standard packages feature a ...
(Date:2/10/2016)... Boston, MA (PRWEB) , ... February 10, 2016 ... ... system is now available on Microsoft Azure. On Azure, Arvados provides capabilities for ... “We saw clear demand for Microsoft Azure from major institutions collecting and analyzing ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
Breaking Biology News(10 mins):